# Cancer drug trade margin capped at 30%, prices may fall 70% 2026-10-08T20:31:11+00:00 | Governance | Indian Opinion Desk Corroboration: 2 independent outlets The government has capped the trade margin on all non-scheduled anti-cancer drugs at a maximum of 30 per cent, a move aimed at cutting excessive mark-ups and reducing patients' out-of-pocket expenses. The order covers branded and generic, domestic and imported, and patented and non-patented drugs. According to government estimates cited by TV9 Hindi, the decision could bring down the MRP of some drugs by up to 70 per cent and save patients around Rs 2,500 crore each year. Amar Ujala reports the government's aim is to make life-saving cancer medicines more affordable by curbing excessive trade margins. The new regime is expected to take effect by the end of October 2026, TV9 Hindi reported. A similar step taken in 2019 had resulted in savings of about Rs 984 crore annually on 526 brands, it added. ## Indian Opinion Analysis Amar Ujala presents the decision as a straightforward affordability measure, leading with the government's stated objective and giving no space to dissent or detail on past implementation. TV9 Hindi covers the same announcement but adds context: it reports the government's estimate of a 70 per cent price cut and Rs 2,500 crore in annual savings, and notes the 2019 precedent that saved Rs 984 crore. The two outlets do not differ in stance, both offer neutral, wire-style reporting. The uniform coverage leaves the reader with the government's own claims untested by independent scrutiny or industry reaction. The key figure to watch is whether the actual price reduction on the ground matches the official estimate of 70 per cent once the order is implemented by the end of October. ## Coverage Coverage: 2 sources, 2 neutral - amarujala.com (neutral report) Leads with government's affordability goal, no criticism or opposition cited - tv9hindi.com (neutral report) Adds savings estimate, 2019 precedent, no critical framing This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Tags: DPCO 2013, Ministry of Health and Family Welfare, NLEM, PIB Canonical: https://indianopinion.org/cancer-drug-trade-margin-capped-at-30-prices-may-fall-70/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/cancer-drug-trade-margin-capped-at-30-prices-may-fall-70/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/